Baudax Bio to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021 Jul 29, 2021 7:00am EDT
Leading Independent Proxy Advisory Firm Glass Lewis & Co. Recommends Baudax Bio Shareholders Vote “For” the Proposed Additional Authorized Shares at Upcoming Special Meeting of Shareholders Jul 01, 2021 7:00am EDT
Leading Independent Advisory Firm Institutional Shareholder Services, Inc. Recommends Baudax Bio Shareholders Vote “For” the Proposed Additional Authorized Shares at Upcoming Special Meeting of Shareholders Jun 30, 2021 7:00am EDT
Baudax Bio Announces Special Meeting of Shareholders to Vote on Proposed Increase in Number of Authorized Shares of Common Stock Jun 18, 2021 4:05pm EDT
Baudax Bio’s ANJESO® Achieves Formulary Listing at Over 100 Institutions in Less Than One Year on the Market Jun 08, 2021 7:00am EDT
Baudax Bio Announces the Cancellation of Adjourned Portion of Annual Shareholder Meeting May 28, 2021 4:05pm EDT
